Company: BAYAU
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001641172-25-002125
Chunk: 1053

Company: Bayview Acquisition Corp
Filing Date: 2025-04-01
Form: 10-K
Item: Item 9B
Chunk 1053
---
    Shares  
    Shares  
    Shares 

    For
                                            the year ended December
                                                                                31,
                                            2024  
    For
                                            the period from February  16,
                                            2023 (inception) to  December
                                            31, 2023 

    Redeemable  
    Non-
    Redeemable  
    Redeemable  
    Non-
    Redeemable 

    Shares  
    Shares  
    Shares  
    Shares 
  
    Basic and diluted net income
    (loss) per share: 

    Numerators: 

    Allocation of
    net loss including accretion of temporary equity 
    $(1,153,705) 
    $(372,461) 
    $(951,427) 
    $(5,693,439)
  
    Income earned on investment
    held in Trust Account 
     2,779,141  
     -  
     107,055  
     - 
  
    Accretion
    of temporary equity to redemption value (extension deposit) 
     500,000  
     -  
     6,623,327  
     - 
  
    Allocation
    of net income (loss) 
    $2,125,436  
    $(372,461) 
    $5,778,955  
    $ (5,693,439 )

    Denominators: 

    Weighted-average
    shares outstanding 
     5,417,863  
     1,749,098  
     244,514  
     1,463,197 
  
    Basic
    and diluted net income (loss) per share 
    $0.39  
    $(0.21) 
    $23.63  
    $(3.89)

Concentration
of Credit Risk

Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts
and management believes the Company is not exposed to significant risks on such accounts.

     F-11 

Fair
Value of Financial Instruments

The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value
Measurement,”